Association of Cancer Care Centers’ Post

Our patient focused work discussing the complexities of clinical trials and what they mean in cancer care! - Aakash Desai, MD, MPH O'Neal Comprehensive Cancer Center at UAB UAB Medicine JAMA Fawzi Abu Rous Eric Singhi https://lnkd.in/dS-THBbi #Cancer #OncoDaily #Oncology #PatientCare #ClinicalTrials #CancerCare

October is Breast Cancer Awareness Month This Breast Cancer Awareness Month, PicnicHealth stands in solidarity with all those affected by breast cancer and continues to support the cause of early detection, prevention, and research. Existing breast cancer datasets focus only on the care provided within the oncology specialist setting, limiting the view of the patient's experience before and in the early days of their cancer diagnosis and treatment and through their entire cancer journey. PicnicHealth’s approach to real-world data places patients at the center, ensuring the most complete, longitudinal datasets for early breast cancer while empowering patients with visibility into their entire health history. Together, we can make a difference and bring us closer to a world without breast cancer. Learn more about our early breast cancer dataset here: https://lnkd.in/efMqPG2U #BreastCancerAwarenessMonth #realworldevidence #Realworlddata

Breast cancer affects countless lives, and October is a time to raise awareness, show support, and celebrate the ongoing scientific breakthroughs that hold the promise of more effective treatments. At Discovery Life Sciences, we're committed to supporting breast cancer research that can make a real impact on patients’ lives. For example, our Biomarker Services team supported researchers from the City of Hope Comprehensive Cancer Center in their Phase 1 clinical trial for patients with metastatic triple-negative breast cancer.  The results show that the use of the immune checkpoint inhibitor pembrolizumab and the chemotherapy agent doxorubicin resulted in a positive response rate and boosted T cell responses in patients. https://lnkd.in/gEq5u8RQ  We’re proud to contribute to the advancements of the scientific community to improve treatment for those affected by breast cancer. #BreastCancerAwareness #PinkOctober #EndBreastCancer 

#BreastCancerAwarenessMonth Metastatic breast cancer, often labeled as 'stage IV,' arises when breast cancer cells spread beyond the breast to other parts of the body through the blood or lymphatic system. This advanced form demands heightened attention as it represents the complexity and urgency in breast cancer treatments. In this significant month, while we embrace the warriors of all breast cancer stages, we shine an extra light on those facing metastatic breast cancer. Their courage and tenacity inspire us every day. Here's how you can make a difference: - Educate yourself and others about the intricacies of metastatic breast cancer. - Share stories of unwavering strength and hope. - Support research initiatives and organizations dedicated to advanced treatments and care. Discover more about our mission: https://lnkd.in/e6ZxVzA #FridayHarbour #MetastaticCancer #BreastCancerStrong

Understanding Bladder Cancer Stages: A Comprehensive Guide. Bladder cancer, though a serious condition, is often highly treatable, especially when detected early. In our latest blog authored by Dr. Srivathsan Ramani delves deep into the different types and stages of bladder cancer, providing valuable insights into diagnosis, treatment options, and patient prognosis. At Apollo Proton Cancer Centre (APCC), we emphasize the importance of early detection and a multidisciplinary approach to treatment. Our dedicated team of urologists, oncologists, and radiation oncologists work together to create personalized treatment plans tailored to each patient's needs. Read the full blog here: [https://lnkd.in/gJXz6TMJ] Join us in spreading awareness and knowledge about bladder cancer. Together, we can make a difference! #WinningOverCancer #BladderCancer #CancerAwareness #Healthcare #Oncology #ApolloProtonCancerCentre #APCC

New podcast shining a spotlight on cancer research developments This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The ‘dark matter’ behind cancer and Could this ‘Goldilocks’ drug be a non-toxic way to treat breast cancer? In the first article, DDW Editor Reece Armstrong looks into recent research which may explain why cancers can become more aggressive. In the second article, Armstrong covers news of a drug which could be used to treat triple-negative breast cancer with less side effects. https://lnkd.in/geQfy3Fn #CancerResearch #Cancer #Oncology

🌟 Charting the Course in Advanced Prostate Cancer Management: Your Invitation to APCCC 2024 🌟 The Advanced Prostate Cancer Consensus Conference (APCCC) is the epicentre of global collaboration, where experts convene to bring clarity to the most pressing questions in advanced prostate cancer management and treatment. This is your chance to be part of a transformative experience that directly impacts clinical practice. Dive into engaging discussions, gain consensus on complex clinical decisions, and be at the forefront of cutting-edge research. 🌐 Our panel of international experts is as diverse as it is knowledgeable and committed to driving consensus in the face of uncertainty. Check out our world map of panel members and see the breadth of knowledge they bring to the table! 📅 25-27 April 2024 Save your seat at the APCCC 2024 and be a part of the conversation that's shaping the future of clinical care in prostate cancer. Register now and connect with leaders in the field: https://apccc.org/ #APCCC24 #ProstateCancer #ClinicalConsensus #OncologyResearch #MedicalConference #HealthcareCollaboration #CancerCare

🎗️ On Breast Cancer Awareness Month, we are excited to share the launch of the new EORTC 2129-BCG TREAT ctDNA study on Early-Stage Breast Cancer in collaboration with MENARINI Group. The trial is expected to screen more than 1900 early-stage breast cancer patients at 120+ sites in 12 European countries, commencing in Q4 2023. The study will evaluate whether elacestrant can delay the occurrence of metastasis or death compared to standard adjuvant endocrine therapy in early-stage ER+/HER2-breast cancer patients with late ctDNA-relapse. Read the article to learn more: https://lnkd.in/eQMGZMwf Michail Ignatiadis, Emmanouil Saloustros, Wolfgang Janni #BreastCancerAwarenessMonth #PinkOCtober #TREATctDNA #CancerResearch #ClinicalTrials

The treatment of #lungcancer has changed dramatically from decades past, when cytotoxic chemotherapy was the only option. We now have a much better understanding of the different molecular subtypes of lung cancer, and this enables the use of highly effective targeted treatments and immunotherapies, which are also significantly less toxic. November is #LungCancerAwarenessMonth🫁, and at Total Health, we're committed to keeping you updated on the latest developments, in patient-friendly language. At our 2023 West Oncology Virtual Conference for Advanced Practicioners and Nurses, Jason Porter from The West Clinic outlined some of the recent updates in treatment for lung cancer. You can read a summary of Dr. Porter’s presentation here: 👉 https://ow.ly/XbGz50QbIKv You can learn more about lung cancer screening and treatment, in plain language, by visiting the ‘Patient Resources’ section of our website. #LungCancerAwareness #KnowledgeIsEmpowerment #OncEd #Oncology #Education #LungCancer

Check out this informative piece on triple-negative breast cancer (TNBC.)   "About 20% of people with breast cancer have a type called triple-negative breast cancer (TNBC) ... but it can be harder to treat because some common cancer treatments, like anti-hormone and anti-HER2, don't work with TNBC."   At Carcinotech we have developed 3D-printed micro-tumours for both triple-negative, HER2 and Luminal A subtypes for breast cancer. Our technology offers surgeons and oncologists the opportunity to test treatment options, drug responses, and create treatment plans for each individual patient. Improving the chance of survival and quality of life of patients.     Let's continue to work to bring more effective cancer therapies to market. #oncology #breastcancer #clinicalresearch